一个相互通信的纳米系统,用于双重交付.
Beatriz Mayol1, Ana Rodríguez1, Anabel Villalonga1
1Nanosensors and Nanomachines Group, Department of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040 Madrid, Spain. rvillalonga@quim.ucm.es.
Journal of materials chemistry. B
|July 7, 2023
概括
这项研究介绍了一种新的双交付纳米系统. 它使用光和化学触发器释放止痛药和染料,用于先进的纳米材料应用.
科学领域:
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 开发复杂的药物输送系统对于向治疗至关重要.
- 响应刺激的纳米材料可以精确控制货物的释放.
- 设计用于序列和双交付的多组件纳米系统存在独特的挑战.
研究的目的:
- 设计和描述一种用于双重药物输送的新型粒子对粒子相互通信的纳米系统.
- 通过使用不同的物理和化学刺激来实现止痛药和模型染料的触发释放.
- 为了证明纳米颗粒之间酶介导通信的潜力,以控制释放.
主要方法:
- 一个具有光敏感门和乙胆酶的Janus纳米粒子 (Au-mesoporous silica) 的制造.
- 制备第二个半孔纳米粒子,其醇敏感门装有罗达胺B.
- 药物和染料释放的顺序触发使用近紫外线光和N-乙thiocholine.
主要成果:
- 成功合成了具有独特功能的双组件纳米系统.
- 光照射触发了从Janus纳米粒子中释放的青的释放.
- 在Janus纳米颗粒上由乙胆酶对N-乙thiocholine的酶转化启动了第二个纳米颗粒中的Rhodamine B的释放.
结论:
- 开发的纳米系统可以通过直角刺激触发可控的,顺序的双重传递.
- 这种粒子对粒子互通策略为先进的纳米材料应用提供了一个多功能平台.
- 该系统展示了止痛药和模型染料的有效释放,为复杂的治疗策略铺平了道路.
更多相关视频
14:36Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
Published on: August 26, 2009
11.2K
06:57Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
Published on: August 11, 2018
7.9K
相关概念视频
Drug Delivery: Overview
326
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
326
Drug Delivery: Miscellaneous Routes
402
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
402
Drug Delivery: Parenteral Route
637
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
637
Drug Delivery: Enteral Route
518
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
518
Carrier-Mediated Transport
471
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
471
